The Trump administration is expected to announce that Stephen M. Hahn. MD, chief medical executive and professor of radiation oncology at The University of Texas MD Anderson Cancer Center, is the next FDA commissioner, according to reporting by The Wall Street Journal.
The term of acting commissioner, Ned Sharpless, MD, expires Nov. 1. But if Hahn is nominated, Sharpless could stay on at the FDA until Hahn is confirmed by the Senate.
Hahn earned his medical degree from Temple University in Philadelphia and completed postgraduate training at the National Cancer (Read more...)
Uncategorized